ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Aclarion Inc

Aclarion Inc (ACON)

5,36
-0,91
(-14,51%)
Geschlossen 08 Februar 10:00PM
5,063
-0,297
(-5,54%)
Nach Börsenschluss: 1:59AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
5,063
Gebot
5,06
Fragen
5,23
Volumen
418.019
4,6801 Tagesbereich 6,40
0,0275 52-Wochen-Bereich 20,84
Marktkapitalisierung
Handelsende
6,27
Handelsbeginn
6,16
Letzte Trade
47
@
5.1
Letzter Handelszeitpunkt
Finanzvolumen
US$ 2.259.867
VWAP
5,4061
Durchschnittliches Volumen (3 Mio.)
39.219.280
Ausgegebene Aktien
131.940
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,14
Gewinn pro Aktie (EPS)
-37,22
Erlöse
75k
Nettogewinn
-4,91M

Über Aclarion Inc

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.

Sektor
Medical Laboratories
Branche
Medical Laboratories
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Aclarion Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker ACON. The last closing price for Aclarion was US$6,27. Over the last year, Aclarion shares have traded in a share price range of US$ 0,0275 to US$ 20,84.

Aclarion currently has 131.940 shares in issue. The market capitalisation of Aclarion is US$827.263,80 . Aclarion has a price to earnings ratio (PE ratio) of -0.14.

ACON Neueste Nachrichten

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while...

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

The Company has secured nearly $20 million in gross proceeds in 2025 ensuring complete funding for its pivotal CLARITY trial CLARITY is a prospective, randomized, multicenter study to validate...

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain...

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a Peer-to-Peer Magazine Published by...

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can...

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Brent Ness, CEO and Director of Aclarion, Inc. (Nasdaq: ACON). As a disruptive healthcare...

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing...

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled...

Aclarion Added to PRISM Emerging Medical Devices Index

Company's industry-first technology addresses chronic low back painAclarion secured its first commercial agreement with Michigan's Sheridan Community HospitalPRISM Emerging Medical Devices Index...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-2.747-35.17285531377.818.775.0517586706.79295131CS
44.92853664.312267660.134520.840.0275982662940.0967687CS
124.9033064.3750.1620.840.0275392192800.12746408CS
264.7731645.862068970.2920.840.0275174372540.12886697CS
523.133162.3316062181.9320.840.027596127800.15055416CS
156-41.337-89.08836206946.464.80.027540268062.50163113CS
260-41.337-89.08836206946.464.80.027540268062.50163113CS

ACON - Frequently Asked Questions (FAQ)

What is the current Aclarion share price?
The current share price of Aclarion is US$ 5,063
How many Aclarion shares are in issue?
Aclarion has 131.940 shares in issue
What is the market cap of Aclarion?
The market capitalisation of Aclarion is USD 827,26k
What is the 1 year trading range for Aclarion share price?
Aclarion has traded in the range of US$ 0,0275 to US$ 20,84 during the past year
What is the PE ratio of Aclarion?
The price to earnings ratio of Aclarion is -0,14
What is the cash to sales ratio of Aclarion?
The cash to sales ratio of Aclarion is 9,04
What is the reporting currency for Aclarion?
Aclarion reports financial results in USD
What is the latest annual turnover for Aclarion?
The latest annual turnover of Aclarion is USD 75k
What is the latest annual profit for Aclarion?
The latest annual profit of Aclarion is USD -4,91M
What is the registered address of Aclarion?
The registered address for Aclarion is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Aclarion website address?
The website address for Aclarion is www.aclarion.com
Which industry sector does Aclarion operate in?
Aclarion operates in the MEDICAL LABORATORIES sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
780,46M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
140,32M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
215,16M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
72,39M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock